HEADER LIPID BINDING PROTEIN 08-NOV-02 1N69 TITLE CRYSTAL STRUCTURE OF HUMAN SAPOSIN B COMPND MOL_ID: 1; COMPND 2 MOLECULE: SAPOSIN B; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PROACTIVATOR POLYPEPTIDE, SAP-B, SPHINGOLIPID ACTIVATOR COMPND 5 PROTEIN 1, SAP-1, CEREBROSIDE SULFATE ACTIVATOR, CSACT, CS-ACT, COMPND 6 SULFATIDE/GM1 ACTIVATOR, GALACTOSYLCERBROSIDE ACTIVATOR; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PROSAPOSIN, PSAP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: AD494(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-16(B) KEYWDS LIPID BINDING PROTEIN, GLYCOSPHINGOLIPID ACTIVATOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR V.E.AHN,K.F.FAULL,J.P.WHITELEGGE,A.L.FLUHARTY,G.G.PRIVE REVDAT 4 30-JUN-21 1N69 1 COMPND REMARK SEQADV HET REVDAT 4 2 1 HETNAM HETSYN FORMUL ATOM REVDAT 3 11-OCT-17 1N69 1 REMARK REVDAT 2 24-FEB-09 1N69 1 VERSN REVDAT 1 07-JAN-03 1N69 0 JRNL AUTH V.E.AHN,K.F.FAULL,J.P.WHITELEGGE,A.L.FLUHARTY,G.G.PRIVE JRNL TITL CRYSTAL STRUCTURE OF SAPOSIN B REVEALS A DIMERIC SHELL FOR JRNL TITL 2 LIPID BINDING JRNL REF PROC.NATL.ACAD.SCI.USA V. 100 38 2003 JRNL REFN ISSN 0027-8424 JRNL PMID 12518053 JRNL DOI 10.1073/PNAS.0136947100 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.E.AHN,K.F.FAULL,J.P.WHITELEGGE,J.HIGGINSON,A.L.FLUHARTY, REMARK 1 AUTH 2 G.G.PRIVE REMARK 1 TITL EXPRESSION, PURIFICATION, CRYSTALLIZATION AND PRELIMINARY REMARK 1 TITL 2 X-RAY ANALYSIS OF RECOMBINANT HUMAN SAPOSIN B REMARK 1 REF PROTEIN EXPR.PURIF. V. 27 186 2003 REMARK 1 REFN ISSN 1046-5928 REMARK 1 DOI 10.1016/S1046-5928(02)00597-1 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 14613 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 729 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2096 REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 110 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1819 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 90 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.05000 REMARK 3 B22 (A**2) : -3.05000 REMARK 3 B33 (A**2) : 6.11000 REMARK 3 B12 (A**2) : 1.75000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 52.37 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : PEH.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PEH.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N69 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 5 REMARK 5 WARNING REMARK 5 1N69: THE PEH LIGAND IS DISORDERED REMARK 9 REMARK 9 BIOLOGICAL_UNIT: HOMODIMER REMARK 10 REMARK 10 OTHER DETAILS: METHIONINES SUBSTITUTED WITH SELENOMETHIONINE REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1000017570. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9789, 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14644 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 37.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 10.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28900 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD, SE-MET REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SNB, SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: POLYETHYLENE GLYCOL 3350, MAGNESIUM REMARK 280 ACETATE, SODIUM CACODYLATE, PH 5.8, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 295K. THE CRYSTAL WAS TREATED WITH A MOTHER REMARK 280 LIQUOR SOLUTION CONTAINING 0.1% HYDROGEN PEROXIDE PRIOR TO REMARK 280 FREEZING. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.45533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.91067 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.91067 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 31.45533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 3 CHAINS (A,B AND C). CHAINS A AND B FORM REMARK 300 AN ASYMMETRIC HOMODIMER. CHAIN C FORMS A HOMODIMER REMARK 300 WITH A CRYSTALLOGRAPHICALLY RELATED SYMMETRY MATE. REMARK 300 SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL REMARK 300 MOLECULE(S). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 31.45533 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 ASP A 0 REMARK 465 GLU A 79 REMARK 465 GLU B 79 REMARK 465 MET C -1 REMARK 465 ASP C 0 REMARK 465 GLU C 79 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 6 OD2 ASP B 13 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 47 CA - CB - SG ANGL. DEV. = 7.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 22 -9.80 -58.68 REMARK 500 SER B 22 -6.81 -58.51 REMARK 500 ASP C 37 -37.21 -39.07 REMARK 500 ARG C 38 1.64 -60.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 580 DISTANCE = 8.80 ANGSTROMS REMARK 525 HOH B 581 DISTANCE = 8.15 ANGSTROMS REMARK 525 HOH C 585 DISTANCE = 8.79 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE PEH LIGAND IS DISORDERED AND IS PROBABLY A REMARK 600 MIXTURE OF PHOSPHATIDYLETHANOLAMINES WITH DIFFERENT REMARK 600 ACYL CHAIN LENGTHS. THIS ENSEMBLE HAS BEEN MODELLED REMARK 600 AS A SINGLE PHOSPHOLIPID. AS A RESULT, THE PEH ATOMS REMARK 600 C2I, C3F, C3G, C3H AND C3I ARE NOT PRESENT IN THIS MODEL. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 3PE A 300 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PE A 300 DBREF 1N69 A 1 79 UNP P07602 SAP_HUMAN 195 273 DBREF 1N69 B 1 79 UNP P07602 SAP_HUMAN 195 273 DBREF 1N69 C 1 79 UNP P07602 SAP_HUMAN 195 273 SEQADV 1N69 MET A -1 UNP P07602 CLONING ARTIFACT SEQADV 1N69 ASP A 0 UNP P07602 CLONING ARTIFACT SEQADV 1N69 MET B -1 UNP P07602 CLONING ARTIFACT SEQADV 1N69 ASP B 0 UNP P07602 CLONING ARTIFACT SEQADV 1N69 MET C -1 UNP P07602 CLONING ARTIFACT SEQADV 1N69 ASP C 0 UNP P07602 CLONING ARTIFACT SEQRES 1 A 81 MET ASP GLY ASP VAL CYS GLN ASP CYS ILE GLN MET VAL SEQRES 2 A 81 THR ASP ILE GLN THR ALA VAL ARG THR ASN SER THR PHE SEQRES 3 A 81 VAL GLN ALA LEU VAL GLU HIS VAL LYS GLU GLU CYS ASP SEQRES 4 A 81 ARG LEU GLY PRO GLY MET ALA ASP ILE CYS LYS ASN TYR SEQRES 5 A 81 ILE SER GLN TYR SER GLU ILE ALA ILE GLN MET MET MET SEQRES 6 A 81 HIS MET GLN PRO LYS GLU ILE CYS ALA LEU VAL GLY PHE SEQRES 7 A 81 CYS ASP GLU SEQRES 1 B 81 MET ASP GLY ASP VAL CYS GLN ASP CYS ILE GLN MET VAL SEQRES 2 B 81 THR ASP ILE GLN THR ALA VAL ARG THR ASN SER THR PHE SEQRES 3 B 81 VAL GLN ALA LEU VAL GLU HIS VAL LYS GLU GLU CYS ASP SEQRES 4 B 81 ARG LEU GLY PRO GLY MET ALA ASP ILE CYS LYS ASN TYR SEQRES 5 B 81 ILE SER GLN TYR SER GLU ILE ALA ILE GLN MET MET MET SEQRES 6 B 81 HIS MET GLN PRO LYS GLU ILE CYS ALA LEU VAL GLY PHE SEQRES 7 B 81 CYS ASP GLU SEQRES 1 C 81 MET ASP GLY ASP VAL CYS GLN ASP CYS ILE GLN MET VAL SEQRES 2 C 81 THR ASP ILE GLN THR ALA VAL ARG THR ASN SER THR PHE SEQRES 3 C 81 VAL GLN ALA LEU VAL GLU HIS VAL LYS GLU GLU CYS ASP SEQRES 4 C 81 ARG LEU GLY PRO GLY MET ALA ASP ILE CYS LYS ASN TYR SEQRES 5 C 81 ILE SER GLN TYR SER GLU ILE ALA ILE GLN MET MET MET SEQRES 6 C 81 HIS MET GLN PRO LYS GLU ILE CYS ALA LEU VAL GLY PHE SEQRES 7 C 81 CYS ASP GLU HET 3PE A 300 46 HETNAM 3PE 1,2-DISTEAROYL-SN-GLYCEROPHOSPHOETHANOLAMINE HETSYN 3PE 3-SN-PHOSPHATIDYLETHANOLAMINE; 1,2-DIACYL-SN-GLYCERO-3- HETSYN 2 3PE PHOSPHOETHANOLAMINE FORMUL 4 3PE C41 H82 N O8 P FORMUL 5 HOH *90(H2 O) HELIX 1 1 GLY A 1 ASN A 21 1 21 HELIX 2 2 THR A 23 CYS A 36 1 14 HELIX 3 3 ASP A 37 GLY A 40 5 4 HELIX 4 4 GLY A 42 MET A 63 1 22 HELIX 5 5 GLN A 66 VAL A 74 1 9 HELIX 6 6 ASP B 2 ASN B 21 1 20 HELIX 7 7 VAL B 25 GLU B 35 1 11 HELIX 8 8 CYS B 36 GLY B 40 5 5 HELIX 9 9 GLY B 42 MET B 63 1 22 HELIX 10 10 GLN B 66 VAL B 74 1 9 HELIX 11 11 GLY C 1 ASN C 21 1 21 HELIX 12 12 THR C 23 ASP C 37 1 15 HELIX 13 13 ARG C 38 GLY C 40 5 3 HELIX 14 14 GLY C 42 MET C 63 1 22 HELIX 15 15 GLN C 66 GLY C 75 1 10 SSBOND 1 CYS A 4 CYS A 77 1555 1555 2.04 SSBOND 2 CYS A 7 CYS A 71 1555 1555 2.04 SSBOND 3 CYS A 36 CYS A 47 1555 1555 2.03 SSBOND 4 CYS B 4 CYS B 77 1555 1555 2.05 SSBOND 5 CYS B 7 CYS B 71 1555 1555 2.05 SSBOND 6 CYS B 36 CYS B 47 1555 1555 2.03 SSBOND 7 CYS C 4 CYS C 77 1555 1555 2.04 SSBOND 8 CYS C 7 CYS C 71 1555 1555 2.05 SSBOND 9 CYS C 36 CYS C 47 1555 1555 2.04 SITE 1 AC1 11 ARG A 38 LEU A 39 MET A 43 ILE A 51 SITE 2 AC1 11 GLN A 66 HOH A 515 VAL B 29 TYR B 50 SITE 3 AC1 11 TYR B 54 ILE B 59 MET B 65 CRYST1 72.140 72.140 94.366 90.00 90.00 120.00 P 31 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013862 0.008003 0.000000 0.00000 SCALE2 0.000000 0.016006 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010597 0.00000